ANI PHARMACEUTICALS INC — Director's Dealing 2013

Aug 30, 2013

SEC Form 4/A — Form 4/A

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2013-06-19

Reporting Person: PRZYBYL ARTHUR (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-06-19	Common Stock	A	0	—	Acquired	0	Indirect

Footnotes

F1: The Reporting Person is amending this Form 4 to report that no acquisition, direct or indirect, of common stock of ANI PHARMACEUTICALS, INC. (the "Issuer") occurred as a result of the establishment of a rabbi trust pursuant to a Grantor Trust, dated June 18, 2013. The Reporting Person has no pecuniary interest in the Issuer's common stock held by the rabbi trust and does not have any voting or dispositive power with respect to such shares. The Reporting Person will report the acquisition of common stock of the Issuer when such acquisitions occur as a result of distributions to him by the rabbi trust. Beginning on August 28, 2013, shares are to be released ratably on a weekly basis to a broker/dealer, who will sell on behalf of the reporting person a portion of the shares under a 10b5-1 trading plan entered into by the Reporting Person to cover tax withholding obligations, and release the remaining shares to the Reporting Person.